German health funds may reimburse PET (positron emission tomography):
This article was originally published in Clinica
The social court in Leipzig, Germany, has ordered a regional division of the federal guilds' health insurance fund (IKK) to pay for the cost of a positron emission tomography (PET) procedure for a patient suffering from cancer. This is the first time that a statutory health insurance fund has been obliged to reimburse a PET examination, as it is normally considered a procedure for the private sector only. The court also wrote to the combined federal committee, which undertakes health technology assessment, and requested it to reassess it position on the reimbursement of PET and thereby close a loophole in the law.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.